HemaSphere
(Jun 2022)
P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME
- I. Grafakos,
- V. Papadakis,
- K. Antoniadi,
- M. Ampatzidou,
- S. Papargyri,
- C. Kelaidi,
- V. Tzotzola,
- S. Polychronopoulou
Affiliations
- I. Grafakos
- 1 Department of Pediatric Hematology and Oncology (TAO), Agia Sofia Children’s Hospital, Athens, Greece
- V. Papadakis
- 1 Department of Pediatric Hematology and Oncology (TAO), Agia Sofia Children’s Hospital, Athens, Greece
- K. Antoniadi
- 1 Department of Pediatric Hematology and Oncology (TAO), Agia Sofia Children’s Hospital, Athens, Greece
- M. Ampatzidou
- 1 Department of Pediatric Hematology and Oncology (TAO), Agia Sofia Children’s Hospital, Athens, Greece
- S. Papargyri
- 1 Department of Pediatric Hematology and Oncology (TAO), Agia Sofia Children’s Hospital, Athens, Greece
- C. Kelaidi
- 1 Department of Pediatric Hematology and Oncology (TAO), Agia Sofia Children’s Hospital, Athens, Greece
- V. Tzotzola
- 1 Department of Pediatric Hematology and Oncology (TAO), Agia Sofia Children’s Hospital, Athens, Greece
- S. Polychronopoulou
- 1 Department of Pediatric Hematology and Oncology (TAO), Agia Sofia Children’s Hospital, Athens, Greece
- DOI
-
https://doi.org/10.1097/01.HS9.0000849080.56756.8d
- Journal volume & issue
-
Vol. 6
pp.
1437
– 1438
WeChat QR code